NPPB and myocardial infarction: In the study by Voors et al. [11] copeptin is shown to be a stronger biomarker in prediction of death and cardiovascular events than both BNP (brain natriuretic peptide) and NT-pro-BNP (N-terminal pro-BNP) in a population of patients with heart failure after acute myocardial infarction.